October 28, 2021 -- Waters and Sartorius announced that they will partner to provide direct access to mass spectrometry data to improve the accuracy of biopharmaceutical process development.
Waters' BioAccord liquid chromatography-mass spectrometry system will be implemented as a new bioprocess analyzer with data connectivity to Sartorius' Ambr multiparallel bioreactor systems to deliver mass spectral information on drug substances, related analytes, and cell culture media. This combination aims to shorten the biopharmaceutical process development from over a month to two days or less.